References
Sanders, C. C., Sanders, W. E. Microbial resistance to newer generation beta-lactam antibiotics: clinical and laboratory implications. Journal of Infectious Diseases 1985, 151: 399–406.
Collatz, E., Gutmann, L., Williamson, R., Acar, J. F. Development of resistance to beta-lactam antibiotics with special reference to third-generation cephalosporins. Journal of Antimicrobial Chemotherapy 1984, 14, Supplement: 13–21.
Dworzack, D. L., Pugsley, M. P., Sanders, C. C., Horowitz, E. A. Emergence of resistance in gram-negative bacteria during therapy with expanded-spectrum cephalosporins. European Journal of Clinical Microbiology 1987, 6: 456–459.
Sanders, C. C., Sanders, W. E. Clinical importance of inducible beta-lactamases in gram-negative bacteria. European Journal of Clinical Microbiology 1987, 6: 435–437.
Livermore, D. M. Clinical significance of beta-lactamase induction and stable depression in gram-negative rods. European Journal of Clinical Microbiology 1987, 6: 439–445.
Sanders, C. C., Sanders, W. E. Emergence of resistance during therapy with the newer beta-lactam antibiotics: role of inducible beta-lactamases and implications for the future. Reviews of Infectious Diseases 1983, 5: 639–648.
Søgaard, P. Population analysis of susceptibility to cefotaxime inEnterobacteriaceae. Acta Pathologica Microbiologica Immunologica Scandinavica (B) 1985, 93: 365–369.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Søgaard, P., Tauris, P. Bacteraemia caused byEscherichia coli and byEnterobacteriaceae producing inducible chromosomal beta-lactamases. Eur. J. Clin. Microbiol. Infect. Dis. 8, 263–264 (1989). https://doi.org/10.1007/BF01965275
Issue Date:
DOI: https://doi.org/10.1007/BF01965275